<html>
<head>
  <title>Ditching Doses: How Smart Devices Are Revolutionizing Diabetes Management</title>
  <style>
    body {
      margin: 0 auto;
      width: 744px;
      font-family: Source Serif Pro, serif;
      line-height: 32px;
      font-weight: 400;
      color: rgba(0, 0, 0, 0.7);
      font-size: 21px;
    }
    h1, h2, h3 {
      font-family: Source Sans Pro, Helvetica, Arial, sans-serif;
    }
    h1 a, h1 a:visited {
      color: inherit;
      text-decoration: none;
    }
    h1 {
      line-height: 48px;
      font-weight: 600;
      color: rgba(0, 0, 0, 0.85);
      font-size: 42px;
      margin: 32px 0 20px;
    }
    h2 {
      line-height: 32px;
      font-weight: 600;
      color: rgba(0, 0, 0, 0.85);
      font-size: 26px;
      margin: 28px 0;
    }
    h3 {
      line-height: 28px;
      font-weight: 600;
      color: rgba(0, 0, 0, 0.85);
      font-size: 21px;
      margin: 24px 0;
    }
    p {
      margin: 32px 0;
    }
    .created, .published {
      color: rgba(0, 0, 0, 0.55);
      font-size: 15px;
      line-height: 15px;
      margin: 20px 0;
    }
    .created + .published {
      margin-top: -12px;
    }
    blockquote {
      font-family: Georgia, Source Serif Pro, serif;
      font-style: italic;
      font-size: 24px;
      line-height: 36px;
      margin: 48px 120px;
      text-align: center;
    }
    a {
      word-wrap: break-word;
      outline: none;
      text-decoration: none;
      background-color: transparent;
      border: 0;
      color: #008CC9;
    }
    a:hover {
      text-decoration: underline;
    }
    a:visited {
      color: #8C68CB;
    }
    .center {
      text-align: center;
    }
    iframe {
      display: block;
      margin: 44px auto;
    }
    *:not(pre) + pre, pre:first-of-type {
      margin-top: 32px;
      padding-top: 32px;
    }
    pre:only-of-type {
      margin: 32px 0;
      padding: 32px;
    }
    pre {
      background: #F3F6F8;
      overflow-x: auto;
      display: block;
      font-size: 13px;
      font-family: monospace;
      line-height: 13px;
      padding: 0 32px 32px;
      white-space: pre;
    }
    a.embedded {
      background: #F3F6F8;
      display: block;
      padding: 32px;
      margin: 32px 0;
    }
    img {
      height: auto;
      max-width: 100%;
    }
    .slate-image-embed__resize-full-width img {
      width: 100%;
    }
    .series-logo {
      width: 48px;
      height: 48px;
      box-sizing: border-box;
      background-clip: content-box;
      border: 4px solid transparent;
      border-radius: 6px;
      object-fit: scale-down;
      float: left;
    }
    .series-title {
      font-size: 16px;
      font-weight: 600;
      vertical-align: top;
    }
    .series-description {
      color: rgba(0,0,0,.6);
      font-weight: 400;
      font-size: 14px;
      line-height: 20px;
    }
    div {
      margin: 32px 0;
    }
  </style>
</head>
<body>
    <img src="https://media.licdn.com/mediaD5612AQEBbbiSxIa7Jg" alt="" title="" />
      <h1><a href="https://www.linkedin.com/pulse/ditching-doses-how-smart-devices-revolutionizing-diabetes-paddy-iyer-g2ntc">Ditching Doses: How Smart Devices Are Revolutionizing Diabetes Management</a></h1>
    <p class="created">Created on 2024-02-04 01:28</p>
  <p class="published">Published on 2024-02-04 01:46</p>
  <div><h3>Summary:</h3><p>A Comprehensive Three-Part Exploration Covering</p><ol><li><p>Business Insights, </p></li><li><p>Cutting-edge Technologies with Event Streaming and Data Vault 2.0, and </p></li><li><p>The Transformative Power of Analytics &amp; Explorative Data Analysis(EDA).</p></li></ol><p><strong>Part I</strong> unveils the intricate business landscape surrounding diabetic patients as they make the pivotal switch from pills to wearable insulin pumps, unraveling the strategic decisions and patient-centric considerations.</p><p>In <strong>part two</strong>, we journey through the technological advancements at the forefront of healthcare, spotlighting the role of event streaming and the revolutionary impact of adopting Data Vault 2.0 for seamless data modeling.</p><p>The grand finale in <strong>part three</strong> delves deep into Analytics and Explorative Data Analysis(EDA), providing a captivating narrative on how data-driven insights are reshaping the landscape of diabetes care, from historical finger nicks to the promising horizon of personalized and proactive health management.</p><hr><h2>Decoding Diabetes Data: Analytics &amp; Insights for Better Blood Sugar Management</h2><h3>Part 1: From Pills to Pumps — Unveiling the Business Case</h3><ol><li><p><strong>Business Questions</strong></p></li></ol><figure><img data-media-urn="urn:li:digitalmediaAsset:D5612AQHKU9qINySeEQ" src="https://media.licdn.com/dms/image/v2/D5612AQHKU9qINySeEQ/article-inline_image-shrink_1000_1488/article-inline_image-shrink_1000_1488/0/1707010158628?e=1773878400&amp;v=beta&amp;t=0UYPTywxAPB8vmd2lEs9cFQXGJv8xM2bX-pKvqJ6Jas"><figcaption>The Whys, Whats and Hows</figcaption></figure><figure><img data-media-urn="urn:li:digitalmediaAsset:D5612AQHPptEJ8NxRvA" src="https://media.licdn.com/dms/image/v2/D5612AQHPptEJ8NxRvA/article-inline_image-shrink_1500_2232/article-inline_image-shrink_1500_2232/0/1707010878844?e=1773878400&amp;v=beta&amp;t=RROn02mencrho7r-xFOoYG0LJpVmYU2t6ZDV_J6aWsg"><figcaption>Business Drivers, Insights and Benefits</figcaption></figure><p></p><h3>Understanding the Business Requirements/Process for Switching from Pills to Wearable Insulin Devices.</h3><p>Here are the specific business needs and functionalities involved in a diabetic patient transitioning from metformin to a wearable insulin device. Here’s what to consider:</p><p><strong>1. Patient Journey:</strong></p><ul><li><p>Initiation: What triggers the initial discussion about switching medications? (e.g., uncontrolled blood sugar levels, complications, patient preference)</p></li><li><p>Evaluation: How does the healthcare provider assess the patient’s suitability for a wearable insulin device? (e.g., medical history, lifestyle factors, tech literacy)</p></li><li><p>Device Selection: What factors influence the choice of a specific wearable insulin device? (e.g., insurance coverage, features, user-friendliness)</p></li><li><p>Training &amp; Onboarding: How is the patient educated and trained on using the device and mobile app?</p></li><li><p>Monitoring &amp; Adjustments: How are blood sugar levels monitored during the transition, and how are insulin doses adjusted?</p></li><li><p>Feedback &amp; Support: What mechanisms are in place for continuous feedback and support from the healthcare provider?</p></li></ul><p><strong>2. Key Stakeholders:</strong></p><ul><li><p>Patients: What are their needs, concerns, and expectations throughout the transition?</p></li><li><p>Healthcare Providers: What are their responsibilities in managing the transition and patient follow-up?</p></li><li><p>Device Manufacturers: What information and support do they offer to patients and healthcare providers?</p></li><li><p>Insurance Companies: What are their coverage policies for wearable insulin devices and associated apps?</p></li></ul><p><strong>3. Business Functionalities:</strong></p><ul><li><p>Device-Patient Interaction: How does the patient interact with the device to deliver insulin doses?</p></li><li><p>Mobile App Integration: What functionalities does the app offer for monitoring, data visualization, and dose management?</p></li><li><p>Data Communication &amp; Security: How is patient data securely collected, transmitted, and stored?</p></li><li><p>Alerts &amp; Notifications: What alerts and notifications are generated for both patients and healthcare providers?</p></li><li><p>Reporting &amp; Analytics: What reports and insights are available to track patient progress and improve care delivery?</p></li></ul><p><strong>4. Key Challenges:</strong></p><ul><li><p>Patient Adherence: How can patient engagement and adherence to the new treatment plan be ensured?</p></li><li><p>Data Interoperability: How can data from different devices and apps be seamlessly integrated and analyzed?</p></li><li><p>Privacy &amp; Security: How can patient data be protected from unauthorized access and breaches?</p></li><li><p>Cost &amp; Reimbursement: How can the affordability of wearable insulin devices and associated apps be addressed?</p></li></ul><p><strong>5. Success Metrics:</strong></p><ul><li><p>Improved blood sugar control</p></li><li><p>Reduced risk of complications</p></li><li><p>Increased patient satisfaction</p></li><li><p>Optimized healthcare provider workflow</p></li></ul><hr><p><a href="https://www.linkedin.com/pulse/beyond-pill-when-wearable-tech-becomes-your-insulin-lifeline-iyer-fkqjc" target="_blank"><strong>Continue to my Part 2: Finger Nicks to the Future: Harnessing Data Streams and Cloud Technology for Personalized Insulin Management:</strong></a></p><p>That talks on:</p><ul><li><p>Delve into the cutting-edge world of event streaming and cloud technology, the backbone of data collection and analysis in wearable insulin pumps.</p></li><li><p>Discover how Data Vault 2.0, a powerful data modeling approach, helps structure and manage the dynamic data generated by these devices.</p></li><li><p>Witness the transformation of raw data into actionable insights, paving the way for personalized insulin delivery and improved patient outcomes.</p></li></ul></div>
</body>
</html>